Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Eleen Laul
Observed name:
Laul, Eleen
Institution:
University of Zurich
Observed institution:
University of Zurich
ORCID:
0000-0003-0273-1117
Observed ORCID:
0000-0003-0273-1117
OpenAlex ID:
A5063426571
Hitting a Moving Target: Simulation and Crystallography Study of ATAD2 Bromodomain Blockers
2020
·
Aymeric Dolbois
, Laurent Batiste
, et al.
·
ACS Medicinal Chemistry Letters
·
15
Structure-Based Design of CBP/EP300 Degraders: When Cooperativity Overcomes Affinity
2024
·
Iván Cheng-Sánchez
, Katherine Gosselé
, et al.
·
JACS Au
·
6
Selective CBP/EP300 Bromodomain Inhibitors: Novel Epigenetic Tools to Counter TNF-α-Driven Inflammation
2025
·
Katherine A. Gosselé
, Irene Latino
, et al.
·
JACS Au
·
4
PDF
Balancing Stability and Payload Release in Glutathione-Responsive PROTAC Prodrugs Targeting Prostate Cancer
2026
·
Eleen Laul
, Katherine A. Gosselé
, et al.
·
JACS Au
·
2
PDF
Development of a novel class of CBP/EP300 bromodomain inhibitors which block TNF-α induced NFκB signaling
2024
·
Katherine Gosselé
, Irene Latino
, et al.
·
ChemRxiv
·
2
PDF
Two-tier Selectivity in PROTAC-Prodrugs Targeting Prostate Cancer
2025
·
Eleen Laul
, Katherine Gosselé
, et al.
·
ChemRxiv
·
1
PDF
Chemical tools for BAZ2A/B biology: discovery of dual and BAZ2B-selective PROTAC degraders
2026
·
Iván Cheng-Sánchez
, Katherine A. Gosselé
, et al.
·
RSC Medicinal Chemistry
Show more works
View as search
Works count:
8
Citation count:
31
H-index:
3
I10-index:
1
Year
Topic
Type